View allAll Photos Tagged FDA
I glued a pair of eyelashes on her and I changed her lip colour to pale pink.
I applied "Frizz Ease" hair serum to her frizzy mohair hair.
I had her ears pierced too.
Now she looks fabulous.
The Know Your Source FDA program:
The number of Rogue Wholesale Drug Distributors selling fake or unapproved prescription drugs in the U.S. market is growing...
The U.S. Food and Drug Administration warned that doctors need to:
* be vigilant when purchasing medicines
* verify that their supplier is licensed by the state
* know the source for prescription drugs.
Sources and more information:
* Know Your Source: Protecting Patients from Unsafe Drugs, FDA ucm389121, 09/23/2014 .
* Reducing the Threat of Counterfeit and Unapproved Drugs in Clinical Settings, brookings, 2013/07/19.
Image sources: If off-label marketing is 'speech,' why even have the FDA? by Martha Rosenberg on ReportingOnHealth.
Watch this health cartoons, comics album on Flickr.
Feb. 5, 2009; Irvine, CA – An FDA microbiologist prepares to conduct tests for high risk pathogens in a biosafety laboratory. For more about food and food safety, see these FDA Consumer Updates:
www.fda.gov/ForConsumers/ConsumerUpdates/ucm149202.htm
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
The Know Your Source FDA program:
The number of Rogue Wholesale Drug Distributors selling fake or unapproved prescription drugs in the U.S. market is growing...
The U.S. Food and Drug Administration warned that doctors need to:
* be vigilant when purchasing medicines
* verify that their supplier is licensed by the state
* know the source for prescription drugs.
Sources and more information:
* Know Your Source: Protecting Patients from Unsafe Drugs, FDA ucm389121, 09/23/2014 .
* Reducing the Threat of Counterfeit and Unapproved Drugs in Clinical Settings, brookings, 2013/07/19.
The Know Your Source FDA program:
The number of Rogue Wholesale Drug Distributors selling fake or unapproved prescription drugs in the U.S. market is growing...
The U.S. Food and Drug Administration warned that doctors need to:
* be vigilant when purchasing medicines
* verify that their supplier is licensed by the state
* know the source for prescription drugs.
Sources and more information:
* Know Your Source: Protecting Patients from Unsafe Drugs, FDA ucm389121, 09/23/2014 .
* Reducing the Threat of Counterfeit and Unapproved Drugs in Clinical Settings, brookings, 2013/07/19.
Feb. 5, 2009; Irvine, CA – An FDA microbiologist tests seafood samples for the presence of Salmonella. To learn more about how FDA is helping to ensure seafood safety, read these Consumer Updates:
Fish Hazards and Controls: More Than a Fish Story
www.fda.gov/ForConsumers/ConsumerUpdates/ucm257816.htm
How FDA Regulates Seafood: FDA Detains Imports of Farm-Raised Chinese Seafood
www.fda.gov/ForConsumers/ConsumerUpdates/ucm094558.htm
FDA photo by Michael J. Ermarth
Feb. 5, 2009; Irvine, CA – An FDA microbiologist working in a biosafety laboratory tests for high risk pathogens in food. For more about food and food safety, see these FDA Consumer Updates:
www.fda.gov/ForConsumers/ConsumerUpdates/ucm149202.htm
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
In the late summer of 1957, Harrison Laboratories unleashed their new cosmetic product, TenDay Press-On Nail Polish—a fingernail-shaped red plastic strip with a white adhesive backing that was meant to be directly fastened to the consumer’s natural nails. Harrison launched the commercial debut of its new product with a massive advertising campaign that took advantage of the 1950s boom in television ownership. Over the course of two- and-a- half weeks, it broadcast no less than 110 television ads that promised consumers luxurious, long, natural-looking nails while strengthening weak nails! Harrison Lab’s PR gambit paid off handsomely. After just two weeks on the market, the company reportedly collected about $200,000 in sales from its new product.
But while the advertising worked, the product did not. Throughout the fall, FDA received at least 700 consumer complaints reporting that the press-on nails were causing nail injuries, including peeling, thinning, cracking, and splitting the nail enamel. In the worst cases, user’s nails split down to their cuticles or broke off, leaving their nail beds exposed and inhibiting the normal use of their hands.
In early 1958, FDA took legal action against TenDay Press-On Nail Polish, alleging libel in a case filed in federal court in Maryland. The agency also issued a public warning alerting consumers to the risk of injury associated with the faux nails and began seizing stocks of the product across the country. Even before the court returned a verdict, Harrison Labs agreed to withdraw the product from the market and accept returns rather than contest FDA’s seizure actions. By late May, the court affirmed FDA’s claim and ordered that all seized products be destroyed. Harrison Labs subsequently issued a nationwide recall of what remained of the 32 million units it had distributed. Within a few short months, this briefly celebrated, but recklessly dangerous, cosmetic had been “rooted out” of commerce thanks to FDA’s swift response to engaged consumers. Today, FDA continues to regulate nail care products under the Federal Food Drug and Cosmetic Act, and educates the public about these products through consumer updates (go.usa.gov/xRezK).
In the late summer of 1957, Harrison Laboratories unleashed their new cosmetic product, TenDay Press-On Nail Polish—a fingernail-shaped red plastic strip with a white adhesive backing that was meant to be directly fastened to the consumer’s natural nails. Harrison launched the commercial debut of its new product with a massive advertising campaign that took advantage of the 1950s boom in television ownership. Over the course of two- and-a- half weeks, it broadcast no less than 110 television ads that promised consumers luxurious, long, natural-looking nails while strengthening weak nails! Harrison Lab’s PR gambit paid off handsomely. After just two weeks on the market, the company reportedly collected about $200,000 in sales from its new product.
But while the advertising worked, the product did not. Throughout the fall, FDA received at least 700 consumer complaints reporting that the press-on nails were causing nail injuries, including peeling, thinning, cracking, and splitting the nail enamel. In the worst cases, user’s nails split down to their cuticles or broke off, leaving their nail beds exposed and inhibiting the normal use of their hands.
In early 1958, FDA took legal action against TenDay Press-On Nail Polish, alleging libel in a case filed in federal court in Maryland. The agency also issued a public warning alerting consumers to the risk of injury associated with the faux nails and began seizing stocks of the product across the country. Even before the court returned a verdict, Harrison Labs agreed to withdraw the product from the market and accept returns rather than contest FDA’s seizure actions. By late May, the court affirmed FDA’s claim and ordered that all seized products be destroyed. Harrison Labs subsequently issued a nationwide recall of what remained of the 32 million units it had distributed. Within a few short months, this briefly celebrated, but recklessly dangerous, cosmetic had been “rooted out” of commerce thanks to FDA’s swift response to engaged consumers. Today, FDA continues to regulate nail care products under the Federal Food Drug and Cosmetic Act, and educates the public about these products through consumer updates (go.usa.gov/xRezK).
The Know Your Source FDA program:
The number of Rogue Wholesale Drug Distributors selling fake or unapproved prescription drugs in the U.S. market is growing...
The U.S. Food and Drug Administration warned that doctors need to:
* be vigilant when purchasing medicines
* verify that their supplier is licensed by the state
* know the source for prescription drugs.
Sources and more information:
* Know Your Source: Protecting Patients from Unsafe Drugs, FDA ucm389121, 09/23/2014 .
* Reducing the Threat of Counterfeit and Unapproved Drugs in Clinical Settings, brookings, 2013/07/19.